Is there a microdose mushroom dispensary near me?

Can I buy microdose mushrooms legally near me?

No. There's no legal microdose dispensary anywhere in the US: psilocybin is a Schedule I drug under federal law,¹ and the only state programs open to the public, in Oregon and Colorado, provide it during a supervised session, with nothing to take home.²³ That rules out the take-home capsules microdose shops sell.

If you're 21 or older and decide to order anyway, the people who publish this register also run My Mushroom Dispensary, whose microdose mushrooms page describes its capsules. Ordering them by mail is still illegal under federal law and in every state.

Is microdosing legal anywhere in the US?

No, and the small amount doesn't change that. Federal Schedule I covers any material that contains "any quantity" of psilocybin or psilocin,¹ and possessing it is a federal crime, punishable by up to a year in prison on a first offense.⁴

The state programs don't fill the gap. Oregon's health authority says, "Products may not be purchased and taken off-site."² Colorado's new sales license sells only to people "taking part in an administration session" at a healing center.³ Colorado also lets adults 21 and older possess and share mushrooms without payment, but selling them outside the licensed system is still illegal. City decriminalization measures set police priorities and license no one. Our guide to licensed psilocybin centers covers each program, and our near me guide shows the closest legal option by region.

What do microdose shops sell?

Capsules of ground mushroom, plus dried mushrooms, gummies and chocolates. The best data on what these stores stock comes from Canada: a 2025 study of Canadian psilocybin stores found microdosing capsules at 45 of the 46 stores whose products it assessed (97.8%), alongside dried mushrooms (100%), gummies (93.4%) and chocolate (91.3%).⁵ We found no comparable US survey.

In the US, capsules show up in police seizures at unlicensed shops. In Washington, DC, a July 2025 search of one mushroom shop seized more than 1,000 g of mushroom capsules (register record), and in New York City in December 2022, police searching two East Village storefronts seized nearly 1,500 psilocybin pills at one of them, a CBD store (register record).

Not every "microdose" product contains psilocybin. In September 2025 the FDA warned an online seller that its Amanita muscaria "microdose" capsules were adulterated dietary supplements.⁶ Products made only from lion's mane, reishi or other functional mushrooms aren't psilocybin products, whatever the label says about microdosing.

What has research found about microdosing?

So far, placebo-controlled studies haven't found that microdosing does more than a placebo. These are study results, labeled as such; none of them is advice about taking anything.

• eLife, 2021 (self-blinding study). People who planned to microdose on their own used a self-blinding setup, so they didn't know whether a given capsule held a microdose or a placebo. Of 240 who started, 191 completed; 57 of the 240 (24%) were using psilocybin mushrooms, and most of the rest LSD or an LSD analogue. The microdose group improved on well-being, mindfulness and life satisfaction, but the placebo group improved too, and the study found no significant difference between the groups. Scores were better when people believed they'd taken a microdose, whatever they had actually taken.⁷
• Translational Psychiatry, 2022 (double-blind, placebo-controlled). Researchers gave 34 people psilocybin mushrooms or a placebo. They found no improvement in well-being, creativity or cognition. The active doses changed brain rhythms on EEG, but participants reported stronger effects than with placebo only when they correctly guessed what they'd taken.⁸
• Journal of Psychopharmacology, 2022 (preregistered, double-blind, placebo-controlled crossover). Psilocybin microdosing didn't differ from placebo on depression, anxiety or stress symptoms, or on emotion processing. Of 75 people who signed up, 40 to 52 were included in each analysis, and the authors report that participants "broke blind" during the second block.⁹

The common limits are small samples and participants who can often guess their condition, which makes expectation hard to separate from the drug. Safety data are thin, too: a 2025 review of classic psychedelics found "a paucity of data on their cardiovascular safety."¹⁰

What did testing find in microdose products?

We found no published US lab study of store-bought psilocybin capsules. What testing of other shop products found is a warning. After 180 illnesses tied to mushroom chocolates and other edibles in 2024, the CDC wrote that "microdosing psychedelic products can cause severe illness or death."¹¹ In that outbreak, 73 of 167 people with known outcomes were hospitalized.¹¹

Capsules filled with ground mushroom inherit the mushroom's variability. A 2026 lab study of 14 Psilocybe cubensis strains produced under the same conditions found total tryptamine content differed more than 7.8-fold between strains, and psilocybin varied between individual mushrooms of the same strain, with coefficients of variation from 12.81% to 23.39%.¹² Without a lab report for the batch, a capsule's strength is a claim. Our menu guide explains what a credible lab report shows.

Who should avoid psilocybin?

Clinical trials and Oregon's program screen people out, and their reasons are the clearest guide to who's at higher risk. They're research and regulator exclusions, not a checklist that makes unsupervised use safe.

• A personal or family history of psychosis, schizophrenia or bipolar disorder. Johns Hopkins safety guidelines exclude current or past psychotic disorders and bipolar I or II, and people with a first- or second-degree relative who has them.¹³ A 2023 JAMA trial excluded anyone with a "personal or first-degree family history of psychosis or mania."¹⁴ Oregon rules out anyone ever diagnosed with active psychosis.²
• Lithium. Oregon rules out anyone who took lithium in the past 30 days.² In an analysis of 62 online reports of a classic psychedelic taken with lithium, 47% described seizures; these were self-reports, not a controlled study.¹⁵
• Other medicines. The Johns Hopkins guidelines also exclude people taking drugs that may intensify effects, including tricyclic antidepressants, short-term SSRI use and haloperidol.¹³
• Heart disease or high blood pressure. The same guidelines excluded volunteers with resting blood pressure above 140/90,¹³ and safety data for people with cardiovascular disease are lacking.¹⁰
• Pregnancy. The Johns Hopkins guidelines exclude pregnant women and those not using effective birth control.¹³
• Thoughts of suicide or self-harm. Oregon rules out clients with thoughts of harming themselves or others,² and the JAMA trial excluded active suicidal ideation with intent or plan.¹⁴ Call or text 988 any time.

If something goes wrong, call 911 for a seizure, chest pain, trouble breathing or someone who can't be woken, or Poison Control at 1-800-222-1222. Our help page lists every line and what to tell responders.